Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
What Ongoing Research May Clarify A PL 14736 trial (PL 14736 is the pharmaceutical-grade formulation of BPC-157 developed for clinical investigation) was listed on ClinicalTrials.gov for inflammatory bowel disease, though results have not been published as of May 2026 15
While early results are promising, many studies are either small, in-vitro, or not rigorously controlled
Griffith,"Determination of Glutathione and Glutathione Disulfide Using Glutathione Reductase and 2-Vinylpyridine", Anal
FIGURE 14 FIGURE 15 Summary In conclusion, since the wound healing therapy with the standard angiogenic growth factors may be of essential importance, we presented an overview of the stable gastric pentadecapeptide BPC 157 and wound-healing issue
Georgakis GV, Li Y, Humphreys R, Johnson R, Andreeff M , Fiscella M, Pukac L, OBrien S, Albert V, Younes A
Compared to opioid pain management, peptide therapy carries no dependency or addiction potential, no respiratory depression risk, no tolerance development, and no overdose risk
US$ 27.87
US$ 29.11
US$ 26.93
US$ 28.78
US$ 22.69
